Literature DB >> 25707784

Diabetes: Controlling glucose levels in elderly people--benefits versus risks.

Matthew C Riddle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25707784     DOI： 10.1038/nrendo.2015.23

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Severe hypoglycemia and risks of vascular events and death.

Authors:  Sophia Zoungas; Anushka Patel; John Chalmers; Bastiaan E de Galan; Qiang Li; Laurent Billot; Mark Woodward; Toshiharu Ninomiya; Bruce Neal; Stephen MacMahon; Diederick E Grobbee; Andre Pascal Kengne; Michel Marre; Simon Heller
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

2.  Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.

Authors:  Linda G Mellbin; Lars Rydén; Matthew C Riddle; Jeffrey Probstfield; Julio Rosenstock; Rafael Díaz; Salim Yusuf; Hertzel C Gerstein
Journal:  Eur Heart J       Date:  2013-09-02       Impact factor: 29.983

3.  Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.

Authors:  Kasia J Lipska; Joseph S Ross; Yinghui Miao; Nilay D Shah; Sei J Lee; Michael A Steinman
Journal:  JAMA Intern Med       Date:  2015-03       Impact factor: 21.873

4.  Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Authors:  Matthew C Riddle; Walter T Ambrosius; David J Brillon; John B Buse; Robert P Byington; Robert M Cohen; David C Goff; Saul Malozowski; Karen L Margolis; Jeffrey L Probstfield; Adrian Schnall; Elizabeth R Seaquist
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

5.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

6.  Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Authors:  F M Turnbull; C Abraira; R J Anderson; R P Byington; J P Chalmers; W C Duckworth; G W Evans; H C Gerstein; R R Holman; T E Moritz; B C Neal; T Ninomiya; A A Patel; S K Paul; F Travert; M Woodward
Journal:  Diabetologia       Date:  2009-08-05       Impact factor: 10.122

7.  Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials.

Authors:  Matthew C Riddle; Diane M Karl
Journal:  Diabetes Care       Date:  2012-10       Impact factor: 19.112

8.  Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial.

Authors:  Michael E Miller; Jeff D Williamson; Hertzel C Gerstein; Robert P Byington; William C Cushman; Henry N Ginsberg; Walter T Ambrosius; Laura Lovato; William B Applegate
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

9.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.

Authors:  Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney
Journal:  BMJ       Date:  2010-01-08

10.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.